Precision BioSciences, Inc.
6 clinical trials · Sponsor
◉ Watch Precision BioSciences, Inc.
| Record | Firm | Date |
|---|---|---|
| PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD) (NCT07429240) | Precision BioSciences, Inc. | 2026-04-24 |
| A Long-term Observational Study in Participants Who Have Received PBGENE-HBV (NCT07254208) | Precision BioSciences, Inc. | 2025-12-25 |
| Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B (NCT06680232) | Precision BioSciences, Inc. | 2024-11-14 |
| Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies (NCT04649112) | Precision BioSciences, Inc. | 2021-06-16 |
| A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants With Relapsed/Refractory Multiple Myeloma (NCT04171843) | Precision BioSciences, Inc. | 2020-04-30 |
| Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL (NCT04030195) | Precision BioSciences, Inc. | 2020-03-24 |
Track Precision BioSciences, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.